ImmuneOnco Biopharmaceuticals Partners with Yangtze River Pharmaceutical to Boost Pipeline Development
ImmuneOnco Biopharmaceuticals (Shanghai) Co., Ltd (HKG: 1541), a biopharmaceutical company based in China, has entered...
Yangtze River Pharmaceutical
Shanghai Unveils Massive Investment Projects and Funds to Boost High-Tech Industries
Shanghai has unleashed a flurry of policy-backed project signings and initiatives, marking a significant boost...
ClouDr Partners with Yangtze River Pharmaceutical to Digitize Chronic Disease Marketing
Hangzhou Kang Ming Information Technology Co., Ltd, trading as “ClouDr” (HKG: 9955), has entered into...
Round 8 VBP Tender Results: RMB 3.775 Billion Awarded Across 152 Manufacturers
The official results of Round 8 of China’s national Volume-Based Procurement (VBP) tender program have...
Boehringer Ingelheim Wins Patent Infringement Ruling Against HEC Over Trajenta
The China National Intellectual Property Administration (CNIPA) has ruled in favor of German pharmaceutical giant...